These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 4981171)
1. [The primary proliferative processes of the hemopoietic system]. Introzzi P Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171 [No Abstract] [Full Text] [Related]
2. [Diffuse lymphatic hyperplasia, lymphoma and pseudolymphoma of the gastrointestinal system]. Rösch W; Fuchs H Dtsch Med Wochenschr; 1972 Jun; 97(22):878-81. PubMed ID: 4624285 [No Abstract] [Full Text] [Related]
3. [New concepts in the classification of malignant hemopathies]. Rappaport H Bull Cancer; 1974; 61(1):11-22. PubMed ID: 4218497 [No Abstract] [Full Text] [Related]
4. Leukaemia and allied disorders. 3. Clinical findings in 200 personal cases. Woodliff HJ Med J Aust; 1972 Aug; 2(8):408-13. PubMed ID: 4628709 [No Abstract] [Full Text] [Related]
5. [Cytological examination of the lymph nodes in lympho-proliferative diseases]. VISCA U; FORNI A Recenti Prog Med; 1962 Dec; 33():507-68. PubMed ID: 13997474 [No Abstract] [Full Text] [Related]
6. Enzymes of round cell tumours in bone and soft tissue: a histochemical survey. Jeffree GM J Pathol; 1974 Jun; 113(2):101-15. PubMed ID: 4278817 [No Abstract] [Full Text] [Related]
7. [Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies]. Berceanu S; Gociu M Stud Cercet Med Interna; 1969; 10(3):197-208. PubMed ID: 4186583 [No Abstract] [Full Text] [Related]
8. [Immunological behavior of patients with malignant blood diseases]. Luca N Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394 [No Abstract] [Full Text] [Related]
9. [The pathology of leukemias and malignant lymphomas in childhood (report) (author's transl)]. Lennert K; Mohri N Verh Dtsch Ges Pathol; 1971; 55():216-69. PubMed ID: 4130720 [No Abstract] [Full Text] [Related]
10. [Acute leukemia syndromes (ALS) appearing during the evolution of hematosarcomas and chronic leukemias (clinical analysis)]. Mathé G; Tubiana M; Calman F; Schlumberger JR; Berumen L; Choquet C; Cattan A; Schneider M Nouv Rev Fr Hematol; 1967; 7(4):543-54. PubMed ID: 4228678 [No Abstract] [Full Text] [Related]
11. [Lympho-reticuloproliferative diseases--problems of differential diagnosis]. Stavem P Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2248-50. PubMed ID: 4216118 [No Abstract] [Full Text] [Related]
12. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases]. Havemann K; Schmidt M; Malchow H; Sodomann CP Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105 [No Abstract] [Full Text] [Related]
13. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses]. Musshoff K Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792 [No Abstract] [Full Text] [Related]
14. [Results of cytostatic therapy of malignant hemoblastoses]. Stacher A Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311 [No Abstract] [Full Text] [Related]
15. [Immunological aspects of malignant lymphoproliferative diseases]. Rivero I; Diumenjo M Rev Clin Esp; 1977 Mar; 144(6):403-9. PubMed ID: 140441 [No Abstract] [Full Text] [Related]
16. [The morpho-functional test of blood lymphocytes in proliferative blood diseases. Case reports]. D'Arrigo S; Lanza C; Lazzaro C Riv Patol Clin Sper; 1968; 9(1):3-18. PubMed ID: 4973516 [No Abstract] [Full Text] [Related]
17. CONCEPT OF RETICULOENDOTHELIOSIS. KOJIMA M; TAKAHASHI K Tohoku J Exp Med; 1965 Mar; 85():120-42. PubMed ID: 14285075 [No Abstract] [Full Text] [Related]
18. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes. Topolska P; Gürtler-Krawczyńska E Pol Med J; 1968; 7(2):372-9. PubMed ID: 5241714 [No Abstract] [Full Text] [Related]
19. [Data on leukemia statistics in the cities of Sochi and Tuapse (1960-71)]. Lebedev VN; Agaeva EM; Belikova SG; Savatenko VG Vopr Onkol; 1975; 21(8):50-4. PubMed ID: 126530 [No Abstract] [Full Text] [Related]
20. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease]. Meier EC; Grob PJ Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059 [No Abstract] [Full Text] [Related] [Next] [New Search]